Report cover image

Global Freund Adjuvant Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 107 Pages
SKU # APRC20354237

Description

Summary

According to APO Research, The global Freund Adjuvant market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Freund Adjuvant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Freund Adjuvant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Freund Adjuvant is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Freund Adjuvant include Shanghai Maokang Biotechnology, DIYIBio, Beyotime, Wako Pure Chemical Industries, Thermo Scientific, Sigma Aldrich, Rockland Immunochemicals, MP Biomedicals and InvivoGen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Freund Adjuvant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Freund Adjuvant.

The Freund Adjuvant market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Freund Adjuvant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Freund Adjuvant Segment by Company

Shanghai Maokang Biotechnology
DIYIBio
Beyotime
Wako Pure Chemical Industries
Thermo Scientific
Sigma Aldrich
Rockland Immunochemicals
MP Biomedicals
InvivoGen
Creative Diagnostics
Advanced Biomart

Freund Adjuvant Segment by Type

Freunds Complete Adjuvant (FCA)
Freunds Incomplete Adjuvant (FICA)

Freund Adjuvant Segment by Application

Medicine
Scientific Research

Freund Adjuvant Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Freund Adjuvant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Freund Adjuvant and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Freund Adjuvant.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Freund Adjuvant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Freund Adjuvant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

107 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Freund Adjuvant Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Freund Adjuvant Sales Estimates and Forecasts (2020-2031)
1.3 Freund Adjuvant Market by Type
1.3.1 Freunds Complete Adjuvant (FCA)
1.3.2 Freunds Incomplete Adjuvant (FICA)
1.4 Global Freund Adjuvant Market Size by Type
1.4.1 Global Freund Adjuvant Market Size Overview by Type (2020-2031)
1.4.2 Global Freund Adjuvant Historic Market Size Review by Type (2020-2025)
1.4.3 Global Freund Adjuvant Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Freund Adjuvant Sales Breakdown by Type (2020-2025)
1.5.2 Europe Freund Adjuvant Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Freund Adjuvant Sales Breakdown by Type (2020-2025)
1.5.4 South America Freund Adjuvant Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Freund Adjuvant Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Freund Adjuvant Industry Trends
2.2 Freund Adjuvant Industry Drivers
2.3 Freund Adjuvant Industry Opportunities and Challenges
2.4 Freund Adjuvant Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Freund Adjuvant Revenue (2020-2025)
3.2 Global Top Players by Freund Adjuvant Sales (2020-2025)
3.3 Global Top Players by Freund Adjuvant Price (2020-2025)
3.4 Global Freund Adjuvant Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Freund Adjuvant Major Company Production Sites & Headquarters
3.6 Global Freund Adjuvant Company, Product Type & Application
3.7 Global Freund Adjuvant Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Freund Adjuvant Market CR5 and HHI
3.8.2 Global Top 5 and 10 Freund Adjuvant Players Market Share by Revenue in 2024
3.8.3 2023 Freund Adjuvant Tier 1, Tier 2, and Tier 3
4 Freund Adjuvant Regional Status and Outlook
4.1 Global Freund Adjuvant Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Freund Adjuvant Historic Market Size by Region
4.2.1 Global Freund Adjuvant Sales in Volume by Region (2020-2025)
4.2.2 Global Freund Adjuvant Sales in Value by Region (2020-2025)
4.2.3 Global Freund Adjuvant Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Freund Adjuvant Forecasted Market Size by Region
4.3.1 Global Freund Adjuvant Sales in Volume by Region (2026-2031)
4.3.2 Global Freund Adjuvant Sales in Value by Region (2026-2031)
4.3.3 Global Freund Adjuvant Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Freund Adjuvant by Application
5.1 Freund Adjuvant Market by Application
5.1.1 Medicine
5.1.2 Scientific Research
5.2 Global Freund Adjuvant Market Size by Application
5.2.1 Global Freund Adjuvant Market Size Overview by Application (2020-2031)
5.2.2 Global Freund Adjuvant Historic Market Size Review by Application (2020-2025)
5.2.3 Global Freund Adjuvant Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Freund Adjuvant Sales Breakdown by Application (2020-2025)
5.3.2 Europe Freund Adjuvant Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Freund Adjuvant Sales Breakdown by Application (2020-2025)
5.3.4 South America Freund Adjuvant Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Freund Adjuvant Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Shanghai Maokang Biotechnology
6.1.1 Shanghai Maokang Biotechnology Comapny Information
6.1.2 Shanghai Maokang Biotechnology Business Overview
6.1.3 Shanghai Maokang Biotechnology Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shanghai Maokang Biotechnology Freund Adjuvant Product Portfolio
6.1.5 Shanghai Maokang Biotechnology Recent Developments
6.2 DIYIBio
6.2.1 DIYIBio Comapny Information
6.2.2 DIYIBio Business Overview
6.2.3 DIYIBio Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.2.4 DIYIBio Freund Adjuvant Product Portfolio
6.2.5 DIYIBio Recent Developments
6.3 Beyotime
6.3.1 Beyotime Comapny Information
6.3.2 Beyotime Business Overview
6.3.3 Beyotime Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beyotime Freund Adjuvant Product Portfolio
6.3.5 Beyotime Recent Developments
6.4 Wako Pure Chemical Industries
6.4.1 Wako Pure Chemical Industries Comapny Information
6.4.2 Wako Pure Chemical Industries Business Overview
6.4.3 Wako Pure Chemical Industries Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Wako Pure Chemical Industries Freund Adjuvant Product Portfolio
6.4.5 Wako Pure Chemical Industries Recent Developments
6.5 Thermo Scientific
6.5.1 Thermo Scientific Comapny Information
6.5.2 Thermo Scientific Business Overview
6.5.3 Thermo Scientific Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Thermo Scientific Freund Adjuvant Product Portfolio
6.5.5 Thermo Scientific Recent Developments
6.6 Sigma Aldrich
6.6.1 Sigma Aldrich Comapny Information
6.6.2 Sigma Aldrich Business Overview
6.6.3 Sigma Aldrich Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sigma Aldrich Freund Adjuvant Product Portfolio
6.6.5 Sigma Aldrich Recent Developments
6.7 Rockland Immunochemicals
6.7.1 Rockland Immunochemicals Comapny Information
6.7.2 Rockland Immunochemicals Business Overview
6.7.3 Rockland Immunochemicals Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Rockland Immunochemicals Freund Adjuvant Product Portfolio
6.7.5 Rockland Immunochemicals Recent Developments
6.8 MP Biomedicals
6.8.1 MP Biomedicals Comapny Information
6.8.2 MP Biomedicals Business Overview
6.8.3 MP Biomedicals Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MP Biomedicals Freund Adjuvant Product Portfolio
6.8.5 MP Biomedicals Recent Developments
6.9 InvivoGen
6.9.1 InvivoGen Comapny Information
6.9.2 InvivoGen Business Overview
6.9.3 InvivoGen Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.9.4 InvivoGen Freund Adjuvant Product Portfolio
6.9.5 InvivoGen Recent Developments
6.10 Creative Diagnostics
6.10.1 Creative Diagnostics Comapny Information
6.10.2 Creative Diagnostics Business Overview
6.10.3 Creative Diagnostics Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Creative Diagnostics Freund Adjuvant Product Portfolio
6.10.5 Creative Diagnostics Recent Developments
6.11 Advanced Biomart
6.11.1 Advanced Biomart Comapny Information
6.11.2 Advanced Biomart Business Overview
6.11.3 Advanced Biomart Freund Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Advanced Biomart Freund Adjuvant Product Portfolio
6.11.5 Advanced Biomart Recent Developments
7 North America by Country
7.1 North America Freund Adjuvant Sales by Country
7.1.1 North America Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Freund Adjuvant Sales by Country (2020-2025)
7.1.3 North America Freund Adjuvant Sales Forecast by Country (2026-2031)
7.2 North America Freund Adjuvant Market Size by Country
7.2.1 North America Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Freund Adjuvant Market Size by Country (2020-2025)
7.2.3 North America Freund Adjuvant Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Freund Adjuvant Sales by Country
8.1.1 Europe Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Freund Adjuvant Sales by Country (2020-2025)
8.1.3 Europe Freund Adjuvant Sales Forecast by Country (2026-2031)
8.2 Europe Freund Adjuvant Market Size by Country
8.2.1 Europe Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Freund Adjuvant Market Size by Country (2020-2025)
8.2.3 Europe Freund Adjuvant Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Freund Adjuvant Sales by Country
9.1.1 Asia-Pacific Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Freund Adjuvant Sales by Country (2020-2025)
9.1.3 Asia-Pacific Freund Adjuvant Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Freund Adjuvant Market Size by Country
9.2.1 Asia-Pacific Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Freund Adjuvant Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Freund Adjuvant Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Freund Adjuvant Sales by Country
10.1.1 South America Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Freund Adjuvant Sales by Country (2020-2025)
10.1.3 South America Freund Adjuvant Sales Forecast by Country (2026-2031)
10.2 South America Freund Adjuvant Market Size by Country
10.2.1 South America Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Freund Adjuvant Market Size by Country (2020-2025)
10.2.3 South America Freund Adjuvant Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Freund Adjuvant Sales by Country
11.1.1 Middle East and Africa Freund Adjuvant Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Freund Adjuvant Sales by Country (2020-2025)
11.1.3 Middle East and Africa Freund Adjuvant Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Freund Adjuvant Market Size by Country
11.2.1 Middle East and Africa Freund Adjuvant Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Freund Adjuvant Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Freund Adjuvant Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Freund Adjuvant Value Chain Analysis
12.1.1 Freund Adjuvant Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Freund Adjuvant Production Mode & Process
12.2 Freund Adjuvant Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Freund Adjuvant Distributors
12.2.3 Freund Adjuvant Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.